Perrigo Co plc (NYSE:PRGO), a global provider of pharmaceutical preparations with annual revenue of $4.39 billion and a market capitalization of $3.42 billion, announced today that Katherine Doyle, an ...

As first reported by News 8 partner Crain’s Grand Rapids Business, Perrigo will be launching Opill within a few weeks, President and CEO Patrick Lockwood-Taylor said during a conference call on ...

Perrigo is exploring new markets with a 'disruptive growth' team, focusing on women's health and GLP-1 side effect relief.

Billy Perrigo is a correspondent at TIME based in the London bureau. He covers the tech industry, focusing on the companies reshaping our world in strange and unexpected ways. His investigation ...